Discovering the In Vivo Pharmacology of Bolt Biotherapeutics’ Immune Checkpoint Modulator ADC: BoltbodyTM Immune-Stimulating Antibody Conjugates (ISACs) for Solid Tumors
Time: 9:00 am
day: Conference Day Two
Details:
- Delving in to the pre-clinical story and in vivo pharmacology of our Boltbody immune stimulating ADC
- Understanding translational challenges and potential hurdles working with immune stimulating ADCs
- What is the future for the Boltbody ADC for solid tumors?
